N4 Pharma (LON:N4P) Stock Price Down 7.7% – Should You Sell?

N4 Pharma Plc ( LON:N4P – Get Free Report ) was down 7.7% during trading on Tuesday . The company traded as low as GBX 0.

55 ($0.01) and last traded at GBX 0.60 ($0.



01). Approximately 432,387 shares changed hands during trading, a decline of 64% from the average daily volume of 1,201,942 shares. The stock had previously closed at GBX 0.

65 ($0.01). N4 Pharma Stock Down 7.

7 % The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.

62. The stock has a market capitalization of £2.37 million, a P/E ratio of -55.

00 and a beta of -0.37. The stock’s 50 day simple moving average is GBX 0.

63 and its 200 day simple moving average is GBX 0.58. N4 Pharma Company Profile ( Get Free Report ) N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom.

It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom. Further Reading Five stocks we like better than N4 Pharma Ride Out The Recession With These Dividend Kings Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor What is the Dogs of the Dow Strategy? Overview and Examples Why Warren Buffett Is Selling: A Look at His Latest Market Moves The 3 Best Fintech Stocks to Buy Now Why Amazon Shares May Never Trade Below $200 Again Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.

com's FREE daily email newsletter ..